Journal of Cardiac Failure
Volume 15, Issue 9 , Pages 805-811 , November 2009

Anti-Alzheimer's Drug, Donepezil, Markedly Improves Long-Term Survival After Chronic Heart Failure in Mice

  • Takemi Handa, MD

      Affiliations

    • Department of Cardiovascular Control, Kochi Medical School, Nankoku, Japan
    • Department of Cardiovascular Surgery, Kochi Medical School, Nankoku, Japan
    • Corresponding Author InformationCorrespondence to: Takemi Handa, Department of Cardiovascular Control, Kochi Medical School, Nankoku, Kochi 783-8505, Japan. Tel: (+81) 88-880-2309; Fax: (+81) 88-880-2310.
    • ,
  • Rajesh G. Katare, MD

      Affiliations

    • Department of Cardiovascular Control, Kochi Medical School, Nankoku, Japan
    • ,
  • Yoshihiko Kakinuma, MD

      Affiliations

    • Department of Cardiovascular Control, Kochi Medical School, Nankoku, Japan
    • ,
  • Mikihiko Arikawa, PhD

      Affiliations

    • Department of Cardiovascular Control, Kochi Medical School, Nankoku, Japan
    • ,
  • Motonori Ando, PhD

      Affiliations

    • Department of Cardiovascular Control, Kochi Medical School, Nankoku, Japan
    • ,
  • Shiro Sasaguri, MD

      Affiliations

    • Department of Cardiovascular Surgery, Kochi Medical School, Nankoku, Japan
    • ,
  • Fumiyasu Yamasaki, MD

      Affiliations

    • Department of Clinical Laboratory, Kochi Medical School, Nankoku, Japan
    • ,
  • Takayuki Sato, MD

      Affiliations

    • Department of Cardiovascular Control, Kochi Medical School, Nankoku, Japan

Received 22 December 2008 ,Revised 17 April 2009 ,Accepted 7 May 2009.

References 

  1. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation. 2004;109:120–124
  2. Ando M, Katare RG, Kakinuma Y, Zhang D, Yamasaki F, Muramoto K, et al. Efferent vagal nerve stimulation protects heart against ischemia-induced arrhythmias by preserving connexin43 protein. Circulation. 2005;112:164–170
  3. Kakinuma Y, Ando M, Kuwabara M, Katare RG, Okudela K, Kobayashi M, et al. Acetylcholine from vagal stimulation protects cardiomyocytes against ischemia and hypoxia involving additive non-hypoxic induction of HIF-1 alpha. FEBS Lett. 2005;579:2111–2118
  4. Katare RG, Ando M, Kakinuma Y, Arikawa M, Handa T, Yamasaki F, et al. Vagal stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of the bradycardiac effect. J Thorac Cardiovasc Surg. 2008;137:223–231
  5. Sato K, Urbano R, Yu C, Yamasaki F, Sato T, Robertson D, et al. Protective effect of donepezil on cardiovascular mortality. [abstract] Circulation. 2008;117:e269
  6. Scheuermann-Freestone M, Freestone NS, Langenickel T, Höhnel K, Dietz R, Willenbrock R. A new model of congestive heart failure in the mouse due to chronic volume overload. Eur J Heart Fail. 2001;3:535–543
  7. Sutherland FJ, Shattock MJ, Baker KE, Hearse DJ. Mouse isolated perfused heart: characteristics and cautions. Clin Exp Pharmacol Physiol. 2003;30:867–878
  8. Sato T, Shishido T, Kawada T, Miyano H, Miyashita H, Inagaki M, et al. ESPVR of in situ rat left ventricle shows contractility-dependent curvilinearity. Am J Physiol Heart Circ Physiol. 1998;274:H1429–H1434
  9. Kameyama T, Chen Z, Bell SP, Fabian J, Lewinter MM. Mechanoenergetic studies in isolated mouse hearts. Am J Physiol Heart Circ Physiol. 1998;274:H366–H374
  10. Claessens TE, Georgakopoulos D, Afanasyeva , Vermeersch SJ, Millar HD, et al. Nonlinear isochrones in murine left ventricular pressure-volume loops: how well does the time-varying elastance concept hold?. Am J Physiol Heart Circ Physiol. 2006;290:H1474–H1483
  11. Mirsky I, Tajimi T, Peterson KL. The development of the entire end-systolic pressure-volume and ejection fraction-afterload relations: a new concept of systolic myocardial stiffness. Circulation. 1987;76:343–356
  12. Packer M, Coats AJ, Flowler MB, Katus HA, Krum H, Mohacsi P, et al. Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651–1658
  13. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med. 1991;325:293–302
  14. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, et al. CHARM Investigators and Committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003;362:759–766
  15. Pitt B, Remme W, Zannad F, Neaton J, Martines F, Roniker B, et al. Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309–1321
  16. Shinke T, Takeuchi M, Takaoka H, Yokoyama M. Beneficial effects of heart rate reduction on cardiac mechanics and energetics in patients with left ventricular dysfunction. Jpn Circ J. 1999;63:957–964
  17. Hu K, Naumann A, Fraccarollo D, Gaudron P, Kaden JJ, Neubauer S, et al. Heart rate reduction by zatebradine reduces infarct size and mortality but promotes remodeling in rats with experimental myocardial infarction. Am J Physiol Heart Circ Physiol. 2004;286:H1281–H1288
  18. Nishikimi T, Hagaman JR, Takahashi N, Kim HS, Matsuoka H, Smithies O, et al. Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene. Cardiovasc Res. 2005;66:94–103
  19. Cox MJ, Hawkins UA, Hoit BD, Tyagi SC. Attenuation of oxidative stress and remodeling by cardiac inhibitor of metalloproteinase protein transfer. Circulation. 2004;109:2123–2128
  20. Kamkin A, Kiseleva I, Wagner KD, Pylaev A, Leiterer KP, Theres H, et al. A possible role for atrial fibroblasts in postinfarction bradycardia. Am J Physiol Heart Circ Physiol. 2002;282:H842–H849
  21. Shepherd G, Klein-Schwartz W, Edwards R. Donepezil overdose: a tenfold dosing error. Ann Pharmacother. 1999;33:812–815
  22. Bordier P, Garrigue S, Barold SS, Bressolles N, Lanusse S, Clémenty J. Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors. Europace. 2003;5:429–431
  23. Vanhaesebroeck B, Alessi DR. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp. Cell Res. 1999;253:210–229
  24. Rogers SL. Perspectives in the management of Alzheimer's disease: clinical profile of donepezil. Dement Geriatr Cogn Disord. 1998;9(Suppl 3):29–42
  25. Maurice T, Meunier J, Feng B, Ieni J, Monaghan DT. Interaction with sigma1 protein, but not N-methyl-D-aspartate receptor, is involved in the pharmacological activity of donepezil. J Pharmacol Exp Ther. 2006;317:606–614
  26. Meunier J, Ieni J, Maurice T. The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor. Br J Pharmacol. 2006;149:998–1012
  27. Kato K, Hayako H, Ishihara Y, Marui S, Iwane M, Miyamoto M. TAK-147, an acetylcholinesterase inhibitor, increases choline acetyltransferase activity in cultured rat septal cholinergic neurons. Neurosci Lett. 1999;260:5–8
  28. Novakova M, Ela C, Barg J, Vogel Z, Hasin Y, Eilam Y. Inotropic action of sigma receptor ligands in isolated cardiac myocytes from adult rats. Eur J Pharmacol. 1995;286:19–30
  29. Kekuda R, Prasad PD, Fei YJ, Leibach FH, Ganapathy V. Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem Biophys Res Commun. 1996;229:553–558
  30. Saxena G, Singh SP, Agrawal R, Nath C. Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice. Eur J Pharmacol. 2008;581:283–289
  31. Auletta CS, Mitchell JM, Richter WR, Taki T, Sagami F. One-year oral toxicity study of donepezil hydrochloride in rats. Jpn Pharmacol Ther. 1998;26(Suppl 6):S1177–S1195
  32. Akinci SB, Ulu N, Yondem OZ, Firat P, Guc MO, Kanbak M, et al. Effect of neostigmine on organ injury in murine endotoxemia: missing facts about the cholinergic anti-inflammatory pathway. World J Surg. 2005;29:1483–1489

 Supported by a grant-in-aid for scientific research (19659355) from the Ministry of Education, Science, Sports, and Culture of Japan, and by a Health and Labor Sciences research grant (H15-KOKORO-019, H16-NANO-005) from the Ministry of Health, Labor, and Welfare of Japan.

PII: S1071-9164(09)00165-1

doi: 10.1016/j.cardfail.2009.05.008

Journal of Cardiac Failure
Volume 15, Issue 9 , Pages 805-811 , November 2009

Article Tools

* Image Usage & Resolution